These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3881033)

  • 21. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
    Stryz JR; Merté HJ
    Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular hypotensive efficacy of 0.25% levobunolol instilled once daily.
    Wandel T; Fishman D; Novack GD; Kelley E; Chen KK
    Ophthalmology; 1988 Feb; 95(2):252-5. PubMed ID: 3050679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of changing medication regimens in glaucoma patients.
    Novack GD; David R; Lee PF; Freeman MI; Duzman E; Batoosingh AL
    Ophthalmologica; 1988; 196(1):23-8. PubMed ID: 3279366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
    Călugăru M
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levobunolol and betaxolol. A double-masked controlled comparison of efficacy and safety in patients with elevated intraocular pressure.
    Long DA; Johns GE; Mullen RS; Bowe RG; Alexander D; Epstein DL; Weiss MJ; Masi RJ; Charap AD; Eto CY
    Ophthalmology; 1988 Jun; 95(6):735-41. PubMed ID: 3062529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glaucoma treatment with once-daily levobunolol.
    Starita RJ; Fellman RL
    Am J Ophthalmol; 1986 Oct; 102(4):544-7. PubMed ID: 3532808
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R; Ober M; Masi R; Elman J; Novack GD; Sears ML; Batoosingh AL
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dose-response study of the effect of levobunolol on ocular hypertension.
    Partamian LG; Kass MA; Gordon M
    Am J Ophthalmol; 1983 Feb; 95(2):229-32. PubMed ID: 6337497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Local subjective tolerance of levobunolol and metipranolol in a double-blind comparative study in patients with increased intraocular pressure].
    Ober M; Scharrer A; Novack GD; Lue JC
    Ophthalmologica; 1986; 192(3):159-64. PubMed ID: 2873545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of timolol maleate and levobunolol. Length of use per 5-ml bottle.
    Meyer MA; Savitt ML
    Ophthalmology; 1994 Oct; 101(10):1658-61. PubMed ID: 7936563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.
    Easthope SE; Perry CM
    Drugs Aging; 2002; 19(3):231-48. PubMed ID: 12027782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long-term safety and efficacy of brinzolamide 1.0% (azopt) in patients with primary open-angle glaucoma or ocular hypertension. The Brinzolamide Long-Term Therapy Study Group.
    March WF; Ochsner KI
    Am J Ophthalmol; 2000 Feb; 129(2):136-43. PubMed ID: 10682964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
    Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
    Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
    Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
    Serle JB; Katz LJ; McLaurin E; Heah T; Ramirez-Davis N; Usner DW; Novack GD; Kopczynski CC;
    Am J Ophthalmol; 2018 Feb; 186():116-127. PubMed ID: 29199013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.
    Derick RJ; Robin AL; Tielsch J; Wexler JL; Kelley EP; Stoecker JF; Novack GD; Coleman AL
    Ophthalmology; 1992 Mar; 99(3):424-9. PubMed ID: 1565455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular pressure after a two-week washout following long-term timolol or levobunolol.
    Hong YJ; Shin DH; Ahn BH; McCarty B
    J Ocul Pharmacol Ther; 1995; 11(2):107-12. PubMed ID: 8564631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.